Medicare drug coverage

Sprycel: 2027 Medicare Part D coverage

27 of 5,495 Part D plans (0%) list Sprycel on their 2027 formulary, the plan's list of covered drugs (down 1 point from 2026). 74% of those require prior authorization, step therapy, or a quantity limit. Plan counts include both Medicare Advantage plans with drug coverage (5,172 MA-PD) and stand-alone drug plans (323 PDP).

License: a US government work, in the public domain (Public Domain Mark 1.0).

Data only, not plan advice. Confirm on Medicare.gov Plan Finder or 1-800-MEDICARE.

2027 compared with 2026

Sprycel is number 93 by total Medicare Part D spending in 2024 ($518 million). Plans that list it most often put it on tier 3 (a tier is the cost level a plan puts a drug on; a lower tier usually costs less). Counts use 7 RxNorm products for this name.

Sprycel Part D coverage, 2026 and 2027
Measure20262027Change
Part D plans in the file5,5185,495-23
Plans that list it31 (1%)27 (0%)-1 point
Prior authorization (of plans that list it)31 (100%)20 (74%)-26 points
Step therapy (of plans that list it)0 (0%)0 (0%)no change
Quantity limit (of plans that list it)21 (68%)20 (74%)+6 points
Any of the three (of plans that list it)31 (100%)20 (74%)-26 points
Not listed or restricted (of all plans)5,518 (100%)5,488 (100%)no change

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

For pharmacies and agencies: check a whole drug list against 2027 formularies.

Upload your patient list or your book of clients and Rivvi checks each drug against the CMS 2027 formulary files, plan by plan, so you see tier changes and new limits before the next refill or open enrollment. Free to start. HIPAA BAA included.

Formulary tier

Sprycel formulary tier, 2026 and 2027
Tier2026 plans2027 plans
Tier 12 (6%)0 (0%)
Tier 30 (0%)21 (78%)
Tier 529 (94%)6 (22%)

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Plan by plan, 2026 to 2027

4,380 plan IDs are in both files. 0 of them (0%) added prior authorization, step therapy, or a quantity limit for Sprycel, and 8 stopped listing it.

Sprycel: plans in both 2026 and 2027
Plan by planPlans
Same plan ID in both years4,380
Listed it in 2026, not in 20278 (0%)
Listed it in 2027, not in 20261 (0%)
Moved it to a higher tier0 (0%)
Added prior authorization0 (0%)
Added step therapy0 (0%)
Added a quantity limit0 (0%)
Added at least one of the three0 (0%)
Removed at least one of the three0 (0%)
Plan IDs new in 20271,115
2026 plan IDs not in the 2027 file1,138

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

States from most to least restrictive

Share of 2027 Part D plans offered in each state that leave Sprycel off the formulary or list it with prior authorization, step therapy, or a quantity limit. 49 states tie for the highest share, 100%; Mississippi ranks last at 96%. States at the same share are ordered by the prior authorization or step therapy share; states equal on both shares share a rank, marked Tied.

States from most to least restrictive for Sprycel, 2027
RankState2027 plansNot listed or restrictedPrior auth or step therapyChange from 2026
1Massachusetts92100%7%no change
2Pennsylvania324100%4%no change
3New Jersey74100%3%no change
Tied 4Alaska9100%0%no change
Tied 4Alabama115100%0%no change
Tied 4Arizona148100%0%no change
Tied 4California397100%0%no change
Tied 4Colorado106100%0%no change
Tied 4Connecticut54100%0%no change
Tied 4District of Columbia21100%0%no change
Tied 4Delaware43100%0%no change
Tied 4Florida549100%0%no change
Tied 4Georgia151100%0%no change
Tied 4Hawaii50100%0%no change
Tied 4Iowa64100%0%no change
Tied 4Idaho45100%0%no change
Tied 4Illinois133100%0%no change
Tied 4Indiana140100%0%no change
Tied 4Kansas84100%0%no change
Tied 4Kentucky123100%0%no change
Tied 4Louisiana126100%0%no change
Tied 4Maryland49100%0%no change
Tied 4Maine52100%0%no change
Tied 4Michigan183100%0%no change
Tied 4Minnesota63100%0%no change
Tied 4Missouri171100%0%no change
Tied 4Montana27100%0%no change
Tied 4North Carolina177100%0%no change
Tied 4North Dakota26100%0%no change
Tied 4Nebraska51100%0%no change
Tied 4New Hampshire25100%0%no change
Tied 4New Mexico68100%0%no change
Tied 4Nevada100100%0%no change
Tied 4New York215100%0%no change
Tied 4Ohio173100%0%no change
Tied 4Oklahoma81100%0%no change
Tied 4Oregon92100%0%no change
Tied 4Rhode Island29100%0%no change
Tied 4South Carolina91100%0%no change
Tied 4South Dakota30100%0%no change
Tied 4Tennessee157100%0%no change
Tied 4Texas412100%0%no change
Tied 4Utah53100%0%no change
Tied 4Virginia145100%0%no change
Tied 4Vermont14100%0%no change
Tied 4Washington114100%0%no change
Tied 4Wisconsin97100%0%no change
Tied 4West Virginia70100%0%no change
Tied 4Wyoming13100%0%no change
50Arkansas8697%0%-3 points
51Mississippi10596%0%-4 points

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

By parent organization

164 parent organizations offer 2027 Part D plans. Humana Inc. has the most, 884, and 100% of them leave Sprycel off or restrict it.

Sprycel coverage by parent organization, 2027
Parent organization2027 plans ↓List itRestrict it (of listing)Not listed or restrictedChange from 2026Plans that added a restriction
INLAND EMPIRE HEALTH PLAN10%none list it100%no change0
Itasca County10%none list it100%no change0
Kern Health Systems (KHS)10%none list it100%no change0
Local Initiative Health Authority for LA County10%none list it100%no change0
Muscogee Creek Nation10%none list it100%new in 20270
Orange County Health Authority10%none list it100%no change0
SAN FRANCISCO HEALTH AUTHORITY10%none list it100%no change0
SAN JOAQUIN COUNTY HEALTH COMMISSION10%none list it100%no change0
SANTA BARBARA SAN LUIS OBISPO REGIONAL HEALTH AUTH10%none list it100%no change0
SANTA CLARA COUNTY HEALTH AUTHORITY10%none list it100%no change0
SANTA CRUZ MONTEREY MERCED SAN BENITO MARIPOSA MAN10%none list it100%no change0
Samaritan Health Services, Inc.10%none list it100%no change0
The Schroer Group, Inc.10%none list it100%no change0
Ventura County Medi-Cal Managed Care Commission10%none list it100%no change0

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Near it by Part D spending

About this data

A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.

A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.